High-throughput laboratory evolution reveals evolutionary constraints in Escherichia coli

Nat Commun. 2020 Nov 24;11(1):5970. doi: 10.1038/s41467-020-19713-w.

Abstract

Understanding the constraints that shape the evolution of antibiotic resistance is critical for predicting and controlling drug resistance. Despite its importance, however, a systematic investigation of evolutionary constraints is lacking. Here, we perform a high-throughput laboratory evolution of Escherichia coli under the addition of 95 antibacterial chemicals and quantified the transcriptome, resistance, and genomic profiles for the evolved strains. Utilizing machine learning techniques, we analyze the phenotype-genotype data and identified low dimensional phenotypic states among the evolved strains. Further analysis reveals the underlying biological processes responsible for these distinct states, leading to the identification of trade-off relationships associated with drug resistance. We also report a decelerated evolution of β-lactam resistance, a phenomenon experienced by certain strains under various stresses resulting in higher acquired resistance to β-lactams compared to strains directly selected by β-lactams. These findings bridge the genotypic, gene expression, and drug resistance gap, while contributing to a better understanding of evolutionary constraints for antibiotic resistance.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Drug Resistance, Multiple, Bacterial / genetics*
  • Escherichia coli* / drug effects
  • Escherichia coli* / genetics
  • Evolution, Molecular*
  • Genes, Bacterial / genetics
  • Genotype
  • Microbial Sensitivity Tests
  • beta-Lactam Resistance / genetics*

Substances

  • Anti-Bacterial Agents